US healthcare giant Johnson & Johnson has announced data from the Phase III ASTRO study of Tremfya (guselkumab) subcutaneous (SC) induction therapy in adults with moderately to severely active ...

Government attacks on press freedom from Mississippi to the Oval Office have our First Amendment rights on the brink of collapse.

What impressed me among the number of effervescent points Coach Deebo made is how earnest he is about taking his craft to the ...

Germany’s Formycon has decided today to prematurely terminate the Phase III trial (Lotus) for its biosimilar candidate FYB206 ...

The administration has blocked the AP from covering a handful of events at the White House this week, including a news conference with India's leader.